| Regulating Pair |
| Introduced Variation |
Knockout of Gcgr |
Protein Info
|
| Induced Change |
Symmetric dimethylarginine concentration: increase (FC = 1.7) |
Metabo Info
|
| Summary |
Introduced Variation
Induced Change
|
|
|
|
|
|
|
|
| Full List of Experiment(s) Validating This Regulating Pair |
| Details of Experiment for Validating This Pair |
[1] |
| Method |
Quantifying the change of symmetric dimethylarginine concentration after GCGR knockout through LC/MS/MRM based metabolomics. |
| Disease Status |
Type 2 diabetes mellitus |
ICD-11: 5A11 |
| Organ/Tissue/Cell Line |
N.A. |
Plasma |
| Subcellular Location |
Membrane (Cell membrane) |
| Tested Species |
Species: Mus musculus (Click to Show/Hide the Complete Species Lineage)
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Rodentia
Family: Muridae
Genus: Mus
Species: Mus musculus
|
| Details |
It is reported that knockout of GCGR leads to the increase of symmetric dimethylarginine levels compared with control group. |
|
|
|
|
|
|
|
| References |
| 1 |
Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes. BMC Genomics. 2011 Jun 1;12:281.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.
